Weijian Lun, Xiaobin Zhang, Yinsheng Hong, Canhua Luo, Yongjia Liu
{"title":"<i>LINC00513</i> promotes colorectal cancer malignant progression by binding with IGF2BP1 to enhance the stability of connective tissue growth factor mRNA.","authors":"Weijian Lun, Xiaobin Zhang, Yinsheng Hong, Canhua Luo, Yongjia Liu","doi":"10.1080/17501911.2024.2373686","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> This study aimed to investigate the role of <i>LINC00513</i> in colorectal cancer (CRC) progression.<b>Materials & methods:</b> Cell proliferation was evaluated using Cell Counting Kit-8. Cell migration was detected with transwell assay. RNA pull-down was applied for verifying the interactions between <i>LINC00513</i>, IGF2BP1 and connective tissue growth factor (<i>CTGF</i>).<b>Results:</b> <i>LINC00513</i>, IGF2BP1 and <i>CTGF</i> levels were upregulated in CRC. Knockdown of <i>LINC00513</i> significantly inhibited the malignant behavior of CRC cells. <i>LINC00513</i> increased <i>CTGF</i> mRNA stability by binding with IGF2BP1. Furthermore, overexpression of IGF2BP1 or <i>CTGF</i> reversed the inhibitory effect of <i>LINC00513</i> shRNA on CRC progression.<b>Conclusion:</b> <i>LINC00513</i> promoted CRC cell malignant behaviors through IGF2BP1/<i>CTGF</i>.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"985-998"},"PeriodicalIF":3.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11404617/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epigenomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17501911.2024.2373686","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: This study aimed to investigate the role of LINC00513 in colorectal cancer (CRC) progression.Materials & methods: Cell proliferation was evaluated using Cell Counting Kit-8. Cell migration was detected with transwell assay. RNA pull-down was applied for verifying the interactions between LINC00513, IGF2BP1 and connective tissue growth factor (CTGF).Results:LINC00513, IGF2BP1 and CTGF levels were upregulated in CRC. Knockdown of LINC00513 significantly inhibited the malignant behavior of CRC cells. LINC00513 increased CTGF mRNA stability by binding with IGF2BP1. Furthermore, overexpression of IGF2BP1 or CTGF reversed the inhibitory effect of LINC00513 shRNA on CRC progression.Conclusion:LINC00513 promoted CRC cell malignant behaviors through IGF2BP1/CTGF.
期刊介绍：
Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community.
Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
